Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
988.3 DKK | -8.81% | -9.69% | -25.69% |
Mar. 27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-25.69% | 5.48M | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- ORPHA Stock
- News Orphazyme A/S
- Orphazyme A/S : Guggenheim Downgrades Orphazyme to Sell From Neutral